PALO ALTO, Calif., March 27, 2025 /PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), today reported recent business highlights and financial results for the fourth quarter and full year ended ...

SEATTLE, March 26, 2025 (GLOBE NEWSWIRE) -- Perspective Therapeutics, Inc. (“Perspective,” the “Company,” “we,” “us,” and “our”) (NYSE AMERICAN ...

Los Angeles had already signed All-Pro wideout Davante Adams to a two-year deal to line up alongside rising star Puka Nacua, but a recent NFL.com mock draft indicates that the Rams may not be done ...

During a fall, a select basket of small-cap stocks have a much better chance of beating an index of 250 stocks,” said Shah. Last week, Indian equities registered one of the best weekly gains in ...

Shares of major carmakers and auto-parts manufacturers fell after President Trump said he would impose 25% tariffs on global automotive imports to the U.S., rekindling concerns about trade ...

and provided recent operational highlights. The Company reported $22.4 million in net revenue from sales of XHANCE during the three-month period ended December 31, 2024, an increase of 13% ...

Memorable styles at recent fashion weeks offer loads of inspiration ... (not unlike notable styles I saw at fashion weeks last fall). For many, keeping hair out of the face and eyes seemed to ...

Kairos Pharma, Ltd. (NYSE American: KAPA), a clinical-stage biopharmaceutical company, highlights activity at recent scientific conferences and announces participation in future events.

Q4 2024 & RECENT HIGHLIGHTS AND MILESTONES Corporate Raised $15.0 million in a private placement financing, enabling the Company to regain compliance with Nasdaq minimum stockholders’ equity ...

CINCINNATI — The Bengals added help on defense in Matt Miller's latest mock draft, picking South Carolina safety Nick Emmanwori in the first round and Tennessee edge rusher James Pearce in the ...

today announced financial results for the fourth quarter and full year 2024, as well as corporate and clinical highlights.

and provides an overview of recent and upcoming business highlights. "Over the last twelve months, Plus has reported very promising safety and efficacy data for our lead drug REYOBIQ administered in ...